Liu, R., Li, Z., Chen, R., Fang, Z., Liu, Z., Liu, H. (2025). EZH2 serves as a viable therapeutic target for myeloma-induced osteolytic bone destruction. Nature Communications. https://doi.org/10.1038/s41467-025-56506-5